SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001171520-22-000371
Filing Date
2022-06-17
Accepted
2022-06-17 16:30:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 eps10316.htm SC 13D/A 148494
  Complete submission text file 0001171520-22-000371.txt   149822
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82442 | Film No.: 221024312
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2200 FLETCHER AVENUE SUITE 501 FORT LEE NJ 07024
Business Address
SINGER JULIAN D. (Filed by) CIK: 0001628706 (see all company filings)

Type: SC 13D/A